We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · May 11, 2021

Disparities in Guideline-Concordant Initial Systemic Treatment in Women With HER2− MBC

Breast cancer (Dove Medical Press)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Breast cancer (Dove Medical Press)
Disparities in Guideline-Concordant Initial Systemic Treatment in Women With HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis
Breast Cancer (Dove Med Press) 2021 Apr 01;13(xx)259-269, A Vyas, M Gabriel, S Kurian

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading